Moreover, when inhibiting Gsk3b activity, diet-induced obese mice significantly improved obesity symptoms, such as body weight gain, increased adiposity, dyslipidemia, and hepatic steatosis, due to the marked reduction of whole-body lipid content [43]. This evidence concerns the gene GSK3B and obesity disorder.